PCM
NUS icon

Portolan Capital Management’s Nu Skin NUS Stock Holding History

Portolan Capital Management’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-596,724
Closed -$5.74M – 160
2025
Q4 		$5.74M Hold
596,724
– – 0.31% 96
2025
Q3 		$7.27M Buy
+596,724
New +$6.27M 0.39% 77
2022
Q1 		– Sell
-13,351
Closed -$678K – 159
2021
Q4 		$678K Sell
13,351
-107,341
-89% -$4.77M 0.05% 126
2021
Q3 		$4.88M Buy
120,692
+22,951
+23% +$1.16M 0.36% 88
2021
Q2 		$5.54M Buy
97,741
+81,340
+496% +$4.63M 0.4% 88
2021
Q1 		$867K Sell
16,401
-35,305
-68% -$1.92M 0.07% 140
2020
Q4 		$2.83M Sell
51,706
-197,631
-79% -$10.4M 0.26% 118
2020
Q3 		$12.5M Buy
249,337
+87,568
+54% +$4.15M 1.41% 14
2020
Q2 		$6.18M Buy
+161,769
New +$5.2M 0.71% 55
2020
Q1 		– Sell
-44,036
Closed -$1.8M – 131
2019
Q4 		$1.8M Sell
44,036
-15,294
-26% -$624K 0.18% 88
2019
Q3 		$2.52M Sell
59,330
-194,017
-77% -$8.14M 0.28% 71
2019
Q2 		$12.5M Buy
+253,347
New +$12.9M 1.34% 23
2019
Q1 		– Sell
-59,734
Closed -$3.66M – 92
2018
Q4 		$3.66M Buy
+59,734
New +$4.03M 0.45% 59
2015
Q4 		– Sell
-42,618
Closed -$1.76M – 135
2015
Q3 		$1.76M Sell
42,618
-25,440
-37% -$1.09M 0.23% 101
2015
Q2 		$3.21M Sell
68,058
-13,531
-17% -$732K 0.45% 83
2015
Q1 		$4.91M Sell
81,589
-86,589
-51% -$4.41M 0.9% 44
2014
Q4 		$7.35M Buy
168,178
+66,386
+65% +$2.93M 1.47% 21
2014
Q3 		$4.58M Buy
101,792
+26,696
+36% +$1.42M 1.04% 37
2014
Q2 		$5.55M Buy
75,096
+69,508
+1,244% +$5.48M 1.21% 28
2014
Q1 		$463K Sell
5,588
-15,289
-73% -$1.34M 0.11% 121
2013
Q4 		$2.89M Sell
20,877
-16,372
-44% -$1.93M 0.64% 65
2013
Q3 		$3.57M Sell
37,249
-10,935
-23% -$928K 0.93% 40
2013
Q2 		$2.94M Buy
+48,184
New +$2.67M 0.84% 47

Other funds holding NUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Portolan Capital Management's NUS Position: Q1 2026 in Review

Portolan Capital Management sold out of Nu Skin (NUS) in Q1 2026, closing a stake of 596,724 shares — an estimated $5.74M sold.

Portolan Capital Management first reported a position in NUS in Q2 2013 and held it in 23 quarters. The position peaked at $12.5M in Q2 2019. 178 funds tracked by Wall St. Rank hold NUS as of Q1 2026.

  • Portolan Capital Management reported no remaining Nu Skin position as of Q1 2026 after selling out during the quarter.
  • Portolan Capital Management sold 596,724 Nu Skin shares in Q1 2026, an estimated $5.74M.
  • Portolan Capital Management first reported a position in Nu Skin in Q2 2013 and held it in 23 quarters.
  • Portolan Capital Management's Nu Skin position peaked at $12.5M in Q2 2019.
  • 178 funds tracked by Wall St. Rank held Nu Skin as of Q1 2026.

Based on Portolan Capital Management's 13F filing for Q1 2026, filed 15 May 2026.